| 1 |
30190454 | Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG study. | 2018 Aug 29 |
2 |
| 2 |
27286995 | Pharmacokinetics, safety, and efficacy of lenalidomide plus dexamethasone in patients with multiple myeloma and renal impairment. | 2016 Jul |
1 |
| 3 |
17686058 | Lenalidomide-induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment-naïve patients undergoing front-line lenalidomide and dexamethasone therapy. | 2007 Sep |
1 |